Efficacy and Pharmacodynamic Modeling of the BTK Inhibitor Evobrutinib in Autoimmune Disease Models
J Immunol 2019;202:2888–2906. DOI: 10.4049/jimmunol.1800583
View and download slide summaries of the latest original articles focusing on therapies in immune-mediated inflammatory diseases including rheumatology, dermatology, and gastroenterology. All materials produced by the team are subsequently reviewed and approved by individual Steering Committee members.
J Immunol 2019;202:2888–2906. DOI: 10.4049/jimmunol.1800583
Lancet. 2019 Jun 8;393(10188):2303-2311
Arthritis Res Ther. 2019 Apr 5;21(1):89.
Ann Rheum Dis. 2019 Aug;78(8):1135-1138.
Mod Rheumatol. 2019 Feb 20:1-23. DOI: 10.1080/14397595.2019.1583711
J Clin Pharm Ther. 2019 Jun;44(3):384-396.
Arthritis Rheumatol. 2019 Jun;71(6):878-891
Arthritis Rheumatol. 2018 Dec;70(12):1923-1932. doi: 10.1002/art.40680
Please click the links below to go to the CSF review of each paper
Rheumatol Ther 2018 Dec;5(2):525-536. DOI 10.1007/s40744-018-0128-0